In COPD-ASMC, the reducing effect of TNF-α on fibronectin expression became only significant at 24 hours (Figure 4(g)), while the expression of α-SMA was significantly reduced after 6 hours (Figure 4(h)). The gene discussed is ACTA1; the disease is chronic obstructive pulmonary disease.